MedTrace Logo

Diabetes Autoimmunity Study in the Young

NCT03205865 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2700

Last updated 2023-03-14

No results posted yet for this study

Summary

Type 1 diabetes (T1D) affects 1.4 million people in the U.S. and its incidence has doubled over the past 20 years. The Diabetes Autoimmunity in the Young Study (DAISY) will estimate overall burden of T1D and other autoimmune diseases in the general population by age 30. The study will evaluate environmental risk factors for development of islet autoimmunity and progression to T1D.

Conditions

  • Type 1 Diabetes Mellitus

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Marian J Rewers, MD, PhD, MPH · Executive Director-Barbara Davis Center for Diabetes, Professor

Eligibility

Min Age
1 Month
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-12-06
Primary Completion
2025-04-30
Completion
2025-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03205865 on ClinicalTrials.gov